4
Changes in Ownership
AMARIN CORP PLCUK Filed Acc 0001209191-19-022107
Chief Scientific Officer sold 9,542 shares at an average $20.06 ($191,392)
- Chief Scientific Officer acquired 9,542 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ketchum Steven B Chief Scientific Officer | 2019-04-01 | Option exercise | +2,605 | $1.40 | $3,647 | 357,097 | D |
| Ketchum Steven B Chief Scientific Officer | 2019-04-01 | Option exercise | +4,166 | $2.50 | $10,415 | 361,263 | D |
| Ketchum Steven B Chief Scientific Officer | 2019-04-01 | Option exercise | +2,771 | $2.95 | $8,174 | 364,034 | D |
| Ketchum Steven B Chief Scientific Officer | 2019-04-01 | Sale | −9,442 | $20.05 | $189,314 | 354,592 | D |
| Ketchum Steven B Chief Scientific Officer | 2019-04-01 | Sale | −100 | $20.78 | $2,078 | 354,492 | D |
| Derivatives | |||||||
| Ketchum Steven B Chief Scientific Officer | 2019-04-01 | Option exercise · Stock Option (Right to Buy) | −2,605 | 26,040 | D | ||
| Ketchum Steven B Chief Scientific Officer | 2019-04-01 | Option exercise · Stock Option (Right to Buy) | −4,166 | 12,498 | D | ||
| Ketchum Steven B Chief Scientific Officer | 2019-04-01 | Option exercise · Stock Option (Right to Buy) | −2,771 | 61,458 | D | ||
| Open-market sales · 9,542 sh · avg $20.06 · $191,392 | |||||||
Loading xslF345X03/doc4.xml…